Toni Valković
- Oncology top 10%
- Immunology
- Molecular Biology
- Hematology top 10%
- Cancer Research
- Co-authors
- Nives JonjićKsenija LučinFranco SassoMauro MelatoClara RizzardiSanja ŠtifterEmina BabarovićDuška Petranović
- Topics
- Multiple Myeloma Research and Treatments (13 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers)Lymphoma Diagnosis and Treatment (6 papers)
- Cited by
- OncologyImmunologyHematology
- Journals
- SHILAP Revista de lepidopterologíaBloodBioMed Research International
- Partner nations
- CroatiaItalyBosnia and Herzegovina
In The Last Decade
Toni Valković
37 papers receiving 573 citations
Peers
Comparison fields: 5 of 72
- Oncology 335
- Immunology 214
- Molecular Biology 194
- Hematology 110
- Cancer Research 75
Countries citing papers authored by Toni Valković
This map shows the geographic impact of Toni Valković's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Toni Valković with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Toni Valković more than expected).
Fields of papers citing papers by Toni Valković
This network shows the impact of papers produced by Toni Valković. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Toni Valković. The network helps show where Toni Valković may publish in the future.
Co-authorship network of co-authors of Toni Valković
This figure shows the co-authorship network connecting the top 25 collaborators of Toni Valković. A scholar is included among the top collaborators of Toni Valković based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Toni Valković. Toni Valković is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 1 | |
| 2 | 1 | |
| 3 | 2 | |
| 4 | 2 | |
| 5 | 2 | |
| 6 | 14 | |
| 7 | 9 | |
| 8 | 26 | |
| 9 | 6 | |
| 10 | 6 | |
| 11 | 24 | |
| 12 | 16 | |
| 13 | Concurrent basal cell and squamous cell carcinomas associated with hydroxyurea therapy. | 5 |
| 14 | 34 | |
| 15 | 3 | |
| 16 | Intravascular lymphoma and thyroid gland. | 5 |
| 17 | 25 | |
| 18 | 5 | |
| 19 | 133 | |
| 20 | 4 |
About Toni Valković
Toni Valković is a scholar working on Hematology, Genetics and Oncology, having authored 42 papers that have together received 586 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (13 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (9 papers) and Lymphoma Diagnosis and Treatment (6 papers). The work is most often cited by research in Oncology (335 citations), Immunology (214 citations) and Hematology (110 citations). Toni Valković has collaborated with scholars based in Croatia, Italy and Bosnia and Herzegovina. Frequent co-authors include Nives Jonjić, Ksenija Lučin, Franco Sasso, Mauro Melato, Clara Rizzardi, Sanja Štifter, Emina Babarović, Duška Petranović, Renata Dobrila-Dintinjana and M. Melato. Their work appears in journals such as SHILAP Revista de lepidopterología, Blood and BioMed Research International.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.